Scilex Holding (NASDAQ:SCLXW – Get Free Report) shares were up 4.7% on Thursday . The stock traded as high as $0.22 and last traded at $0.22. Approximately 220 shares traded hands during mid-day trading, a decline of 98% from the average daily volume of 12,979 shares. The stock had previously closed at $0.21.
Scilex Stock Up 4.7 %
The company’s 50 day moving average price is $0.29 and its two-hundred day moving average price is $0.32.
About Scilex
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
Further Reading
- Five stocks we like better than Scilex
- What is a Stock Market Index and How Do You Use Them?
- Micron Stock Under $100: Seize the AI-Driven Upside
- Election Stocks: How Elections Affect the Stock Market
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- What Are Growth Stocks and Investing in Them
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for Scilex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scilex and related companies with MarketBeat.com's FREE daily email newsletter.
